Abstract
Abstract
Background
Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated.
Methods
Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.
Result
The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI.
Conclusions
In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
Funder
Key Technologies Research and Development Program
Young Scientists Fund
Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Khaltaev N. GARD, a new way to battle with chronic respiratory diseases, from disease oriented programmes to global partnership. J Thorac Dis. 2017;9:4676–89.
2. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. https://www.who.int/gard/publications/GARD_Manual/en/. Date last accessed: March 10, 2019.
3. Ferrante G, Baldissera S, Campostrini S. Epidemiology of chronic respiratory diseases and associated factors in the adult Italian population. Eur J Pub Health. 2017;27:1110–6.
4. Gambaryan MH, Shalnova SA, Deev AD, Drapkina OM. Chronic respiratory diseases in the regions of northern Russia: epidemiological distinctions in the results of a National Population Study. Int J Environ Res Public Health. 2017;14.
5. Yin P, Wang H, Vos T, Li Y, Liu S, Liu Y, Liu J, Wang L, Naghavi M, Murray CJ, Zhou M. A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013: findings from the global Burden of disease study 2013. Chest. 2016;150:1269–80.
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献